Photodynamic Therapy in Treating Patients With Basal Cell Skin Cancer
Status:
Completed
Trial end date:
2007-01-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Photodynamic therapy uses light and drugs that make cancer cells more sensitive to
light to kill tumor cells. Photosensitizing drugs such as HPPH are absorbed by cancer cells
and, when exposed to light, become active and kill the cancer cells.
PURPOSE: Phase I trial to study the effectiveness of photodynamic therapy with HPPH in
treating patients who have basal cell skin cancer.